Assessing disease activity in SLE patients during pregnancy

Branch DW . Physiologic adaptations of pregnancy . Am J Reprod Immunol 1992; 28: 120-122 .

Lockshin MD . Pregnancy does not cause systemic lupus erythematosus to worsen . Arthritis Rheum 1989; 32: 665-670 .

Buyon JP , Nelson JL , Lockshin MD . The effects of pregnancy on autoimmune diseases . Clin Immunol Immunopath 1996; 78: 99-104 .

Kalunian KC, Petri M, Merrill J, Callan C, Hepburn B, Delgado-Herrera L, Buyon JP. Guidelines for use of the SLEDAI: An instrument for clinical trials. (manuscript in preparation).

Hughes EC (ed). Obstetric-Gynecologic Terminology. FA Davis: Philadelphia , 1972.

Scott JR. Hypertensive disorders of pregnancy. In: Scott JR , DiSais PJ , Hammond CB , Spellacy WN (eds). Danforth's Obstetrics and Gynecology, 7th ed. JB Lippincott: Philadelphia , 1994, p 350-350.

Laros RK . Thromboembolic disease. In: Creasy RK , Resnik R (eds). Maternal-Fetal Medicine: Principles and Practice, 2nd ed. W.B. Saunders: Philadelphia , 1989, p 763-763.

Parke AL . antimalarial drugs in pregnancy—the North American experience . Lupus 1996; 5 (Suppl 1): S67-S69 .

Hilsinger RL , Adour KK , Doty HE . Idiopthic facial paralysis, pregnancy, and the menstrual cycle . Ann Otol Rhinol Laryngol 1975; 84: 433-433 .

Wiebers DO . Ischemic cerebrovascular complications of pregnancy . Arch Neurol 1985; 42: 1106-1106 .

Roberts JM . Pregnancy-related hypertension. In: Creasy RK , Resnik R (eds). Maternal-Fetal Medicine: Principles and Practice, 3rd ed W.B. Saunders: Philadelphia , 1999, p 833-833.

Buyon JP , Tamerius J , Odorica S , Abramson SB . Activation of the alternative complement pathway accompanies disease flares in SLE during pregnancy . Arthritis Rheum 1992; 35: 55-61 .

Rapini RP , Jordon RE . The skin and pregnancy. In: Creasy RK , Resnik R (eds). Maternal-Fetal Medicine: Principles and Practice, 2d ed. W.B. Saunders: Philadelphia , 1989, p 1110-1110.

Kitzmiller JL , Stoneburger L , Yelmosky PF , Lucas WE . Serum complement in normal pregnancy and preeclampsia . Am J Obstet Gynecol 1973; 117: 312-315 .

Baines MG , Millar KG , Mills P . Studies of complement levels in normal human pregnancy . Obstet Gynecol 1974; 43: 806-810 .

Abramson SA , Buyon JP . Activation of the complement pathway: comparison of normal pregnancy, preeclampsia, and systemic lupus erythematosus during pregnancy . Am J Reprod Immunol 1992; 28: 183-187 .

Lockshin MD , Harpel PC , Druzin ML et al. Lupus pregnancy II. Unusual pattern of hypocomplementemia and thrombocytopenia in the pregnant patient . Arthritis Rheum 1985; 28: 58-66 .

Levy RA , Qamar T , Lockshin MD . Alternative complement pathway in hypocomplementemic/normal C1s-C1 inhibitor complex patients with SLE . Clin Exp Rheumatol 1990; 8: 11-15 .

Burrows RF , Kelton JG . Incidentally detected thrombocytopenia in healthy mothers and their infants . New Eng J Med 1988; 319: 142-145 .

Petri M , Genovese M , Engle E , Hochberg M . Definition, incidence and clinical description of flare in systemic lupus erythematosus. A prospective cohort study . Arthritis Rheum 1991; 34: 937-944 .

Petri M , Hellmann D , Hochberg M . Validity and reliability of lupus activity measures in the routine clinical setting . J Rheumtol 1992; 19: 53-59 .

Liang MH , Socher SA , Larson MG , Schur PH . Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus . Arthritis Rheum 1989; 32: 1107-1118 .

Fellows of Harvard College. SLE Activity Measure-Revised (SLAM R); 1988 Revised 7=91.

Fortin P et al. Impact of disease activity and cumulative damage on the health of lupus patients . Lupus 1998; 7: 101-107 .

Ramsey-Goldman R , Manzi S , Schilling EM et al. Lupus activity in pregnant and non-pregnant women (abstract) . Arthritis Rheum 1995; 38(Suppl): S219-S219 .

Manzi S , Rairie J , Carpenter AB , Kelly RH et al. Complement split products in plasma and urine in assessing lupus disease activity . Arthritis Rheum 1996; 39: 1178-1188 .

Abrahamowicz M et al. The relationship between disease activity and physician's decision to start treatment in active systemic lupus erythematosus . J Rheumatol 1998; 25: 277-284 .